Life Sciences TDR’s Top 5 Psychedelic Developments For the Week of March 1 Benjamin A. Smith Mar 6, 2021 0
Non-Profit Partnerships a Growing Trend? Havn Life Partners with Heroic Hearts Project for PTSD Studies Dec 9, 2020
Healthcare Professionals Receive Approval from Health Canada to Use Psilocybin on Themselves Dec 8, 2020
Numinus CEO Payton Nyquvest on Building A Compliant, Collaborative Company Ahead of Regulations Dec 8, 2020
PharmaTher Expands Research Partnership with University Health Network For Development of Digital Therapeutics Platform Dec 1, 2020
PharmaTher CEO Fabio Chianelli on Evolving Into Specialty Biotech Company Focused on Ketamine Nov 17, 2020
Amid Psychedelic Rush, Canadian Healthcare Professionals Have Waited 150 Days For Exemptions Nov 16, 2020
What the U.S. Military’s $27M investment in psychedelic drugs could mean for veterans with PTSD Nov 11, 2020
Cybin Comes To Market 3 Weeks After Closing the Largest Raise In Canadian Psychedelics History Nov 10, 2020
The Psychedelic Vote: Here’s What Happened In Washington, D.C. And Oregon During Last Night’s Election Nov 4, 2020
